
Roche’s Sam Ogden joins the ABPI
pharmafile | November 25, 2010 | Appointment | Medical Communications, Sales and Marketing | ABPI, Sam Ogden, appointment, medical communications, sales and marketing
The ABPI has appointed Sam Ogden as membership engagement account director.
She is currently head of in-field effectiveness at Roche and will join the UK pharma industry association on 10 January 2011.
Sam has worked at Roche for ten years, holding a variety of senior sales, marketing and business unit head roles.
Prior to joining Roche she held commercial roles at AstraZeneca and SmithKline Beecham.
In her new role she will be reporting to ABPI commercial director Alison Clough.
Alison said: “Sam will ensure that we engage more proactively with all our members, in particular the small-mid size companies and will play a key role in ensuring their views and needs are fully represented in our campaigns.”
Related Content

Men’s health – a new report from the Department of Health and Social Care
The UK Department of Health and Social Care has published a new report entitled Men’s …

PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025
The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …

David Wheadon appointed to board of directors at Seaport Therapeutics
This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.






